Novel anti-angiogenic effects of formononetin in human colon cancer cells and tumor xenograft

Oncology Reports

Volumn 28, Issue 6, 2012, Pages 2188-2194

  Auyeung, Kathy Ka Wai ^a   Law, Pui Ching ^a   Ko, Joshua Ka Shun ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Angiogenesis; Cell invasiveness; Cell proliferation; Colon cancer; Formononetin

Indexed keywords

ANGIOGENIC FACTOR; DIMETHYL SULFOXIDE; FORMONONETIN; MATRIX METALLOPROTEINASE; VASCULOTROPIN;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; CANCER CELL; CANCER THERAPY; CELL COUNT; CELL INVASION; CELL PROLIFERATION; COLON CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TREATMENT DURATION; TUMOR CELL; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ASTRAGALUS MEMBRANACEUS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; ISOFLAVONES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PHYTOESTROGENS; PLANT EXTRACTS; PLANT ROOTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84868143700     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2056     Document Type: Conference Paper

References (48)

1. Boedefeld WM, Bland KI and Heslin MJ: Recent insights into angiogenesis, apoptosis, invasion, and metastasis in colorectal carcinoma. Ann Surg Oncol 10:839-851, 2003. (Pubitemid 40486847)
2. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174, 2002. (Pubitemid 37328786)
3. Tutton MG, George ML, Eccles SA, Burton S, Swift RI and Abulafi AM: Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients. Int J Cancer 107:541-550, 2003. (Pubitemid 37296113)
4. Bensky D, Gamble A and Kaptchuk TK: Chinese Herbal Medicine Materia Medica. Eastland Press, Seattle, pp358-359, 1993.
5. Zee-Cheng RK: Shi-quan-da-bu-tang (ten significant tonic decoction), SQT. A potent Chinese biological response modifer in cancer immunotherapy, potentiation and detoxifcation of anticancer drugs. Methods Find Exp Clin Pharmacol 14:725-736, 1992. (Pubitemid 23057193)
6. Shao BM, Xu W, Dai H, Tu P, Li Z and Gao XM: A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biochem Biophys Res Commun 320:1103-1111, 2004. (Pubitemid 38916657)
7. Duan P and Wang ZM: Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor. Zhongguo Zhong Xi Yi Jie He Za Zhi 22:515-517, 2002 (In Chinese).
8. Tin MM, Cho CH, Chan K, James AE and Ko JK: Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. Carcinogenesis 28:1347-1355, 2007. (Pubitemid 47062696)
9. Auyeung KK, Cho CH and Ko JK: A novel anticancer effect of Astragalus saponins: transcriptional activation of NSAID-activated gene. Int J Cancer 125:1082-1091, 2009.
10. Shen P, Liu MH, Ng TY, Chan YH and Yong EL: Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J Nutr 136:899-905, 2006.
11. Vaya J, Belinky PA and Aviram M: Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidant capacity toward LDL oxidation. Free Rad Biol Med 23:302-312, 1997.
12. Park J, Kim SH, Cho D and Kim TS: Formononetin, a phytooestrogen, and its metabolites up-regulate interleukin-4 production in activated T cells via increased AP-1 DNA binding activity. Immunology 116:71-81, 2005. (Pubitemid 41208354)
13. Jun. M, Hong J, Jeong WS and Ho CT: Suppression of arachidonic acid metabolism and nitric oxide formation by kudzu isofavones in murine macrophages. Mol Nutr Food Res 49:1154-1159, 2005. (Pubitemid 43004348)
14. Nestel P, Fujii A and Zhang L: An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women. Atherosclerosis 192:184-189, 2007. (Pubitemid 46602296)
15. Huo Y, Guo C, Zhang QY, Chen WS, Zheng HC, Rahman K and Qin LP: Antinociceptive activity and chemical composition of constituents from Caragana microphylla seeds. Phytomedicine 14:143-146, 2007. (Pubitemid 46136947)
16. Dong TTX, Zhao KJ, Gao QT, et al: Chemical and biological assessment of a chinese herbal decoction containing Radix Astragali and Radix Angelicae Sinensis: determination of drug ratio in having optimized properties. J Agric Food Chem 54:2767-2774, 2006.
17. Auyeung KK and Ko JK: Novel herbal flavonoids promote apoptosis but differentially induce cell cycle arrest in human colon cancer cell. Invest New Drugs 28:1-13, 2010. (Pubitemid 46274648)
18. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239-3245, 1987. (Pubitemid 17082655)
19. Auyeung KK, Law PC and Ko JK: Astragalus saponins induce apoptosis via an ERK-independent NF-κB signaling pathway in the human hepatocellular HepG2 cell line. Int J Mol Med 23:189-196, 2009.
20. Ko JKS, Lam FYL and Cheung APL: Amelioration of experimental colitis by Astragalus membranaceus through antioxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol 11:5787-5794, 2005.
21. Kondo Y, Arii S, Mori A, Furutani M, Chiba T and Imamura M: Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line. Clin Cancer Res 6:622-630, 2000. (Pubitemid 30111488)
22. Sukhthankar M, Yamaguchi K, Lee SH, McEntee MF, Eling TE, Hara Y and Baek SJ: A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer. Gastroenterology 134:1972-1980, 2008. (Pubitemid 351783262)
23. Carusi D: Phytoestrogens as hormone replacement therapy: an evidence-based approach. Prim Care Update Ob Gyns 7:253-259, 2000.
24. Liang WC, Wu X, Peale FV, Lee C V, et al: Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J Biol Chem 28:951-961, 2006.
25. Arjmandi BH: The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency. J Am Coll Nutr 20:S398-S402, 2001.
26. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R and Schweigerer L: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Nat Acad Sci USA 90:2690-2694, 1993. (Pubitemid 23113482)
27. Yanagihara K, Ito A, Toge T and Numoto M: Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 3:5815-5821, 1993. (Pubitemid 23360293)
28. Beck V, Rohr U and Jungbauer A: Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? J Steroid Biochem Mol Biol 94:499-518, 2005. (Pubitemid 40616410)
29. Harris AL: Angiogenesis as a new target for cancer control. Eur J Cancer Suppl 1:1-12, 2003. (Pubitemid 38624426)
30. Fukumura D, Xavier R and Sugiura T: Tumor induction of VEGF promoter activity in stromal cells. Cell 94:715-725, 1998. (Pubitemid 28436004)
31. Hanahan D, Christofori G, Naik P and Arbeit J: Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur J Cancer 32 A: 2386-2393, 1996.
32. Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364, 1996. (Pubitemid 26272076)
33. Takebayashi Y, Aklyama S, Yamada K, Akiba S and Aikou T: Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 78:226-231, 1996. (Pubitemid 26234563)
34. Vermeulen PB, Van Den Eynden GG and Huget P: Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer 79:316-322, 1999. (Pubitemid 29002302)
35. Portera CA Jr, Berman RS and Ellis LM: Molecular determinants of colon cancer metastasis. Surg Oncol 7:183-195, 1998.
36. Gutman M and Fidler IJ: Biology of human colon cancer metastasis. World J Surg 19:226-234, 1995.
37. Radinsky R and Ellis LM: Molecular determinants of colon cancer metastasis. Surg Oncol Clin N Am 5:215-229, 1996. (Pubitemid 26132347)
38. Gabbert H: Mechanisms of tumor invasion: evidence from in vivo observations. Cancer Metastasis Rev 4:293-309, 1985.
39. London CA, Sekhon HS, Arora V, Stein DA, Iversen PL and Devi GR: A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity. Cancer Gene Ther 10:823-832, 2003. (Pubitemid 37420041)
40. Nakahara H: Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA 94:7959-7964, 1997. (Pubitemid 27343757)
41. Coussens LM, Fingleton B and Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295:2387-2392, 2002. (Pubitemid 34270240)
42. Fridman R, Toth M, Chvyrkova I, Meroueh SO and Mobashery S: Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 22:153-166, 2003. (Pubitemid 36561055)
43. Zuzga D, Gibbons AV and Li P: Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis. Clin Transl Sci 1:136-141, 2008.
44. Lubbe WJ, Zhou ZY, Fu W, et al: Tumor epithelial cell matrix metalloproteinase-9 is a target for antimetastatic therapy in colorectal cancer. Clin Cancer Res 12:1876-1882, 2006.
45. Curran S and Murray GI: Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 189:300-308, 1999. (Pubitemid 29489213)
46. Lubbe WJ, Zuzga DS, Zhou ZY, et al: Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9. Cancer Res 69:5472-5476, 2009.
47. Rao JS, Bhoopathi P, Chetty C, Gujrati M and Lakka SS: MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16 (INK4a) and mitogen-activated protein kinase pathway. Cancer Res 67:4956-4964, 2007. (Pubitemid 46910204)
48. Bhoopathi P, Chetty C, Kunigal S, Vanamala SK, Rao JS and Lakka SS: Blockade of tumor growth due to MMP-9 inhibition is mediated by sequential activation of β1 integrin, ERK and NFκB. J Biol Chem 283:1545-1552, 2008.